Nakamuraya Co., Ltd. operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nakamuraya Co., Ltd. with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 47.82 billion Indian Rupees [US$670.92 million]
of which 100%
Ismail Industries Limited
(30.19 billion Pakistan Rupees [US$193.20 million]
of which 77%
was Food Processing), and
Imuraya Group Company Limited
(45.11 billion Japanese Yen [US$412.74 million]
of which 87%
was Distribution Business).
Nakamuraya Co., Ltd. reported sales of ¥38.74 billion (US$354.51 million)
March of 2019.
decrease of 6.3%
versus 2018, when the company's sales were ¥41.36 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Nakamuraya Co., Ltd. had sales
of ¥41.57 billion.
Contributing to the drop in overall sales was the 6.5% decline
in Real Estate Leasing Business, from ¥578.36 million to ¥540.52 million.
There were also decreases in sales in
Confectionery Business (down 3.4% to ¥29.48 billion)
Food Business (down 5.8% to ¥8.73 billion)